Myopia has gained increasing interest in recent years, particularly because of its increase in prevalence across populations worldwide. The onset of myopia has shifted to a younger age, and the number of high myopes with prescriptions of more than −5.00 D has increased over the last few decades. High myopia is strongly associated with a greater incidence of pathologic complications, has shown to impact vision-related quality of life in children and adults and is further associated with certain contact lens complications. Different pharmaceutical and optical treatment options are currently under investigation with a common goal to slow down the rate of myopia progression.
Centre for Contact Lens Research (D.J., D.L.), School of Optometry, University of Waterloo, Waterloo, Ontario, Canada.
Address correspondence and reprint requests to Deborah Jones, F.C.Optom., Dip.C.L.P., F.A.A.O., Centre for Contact Lens Research, University of Waterloo, 200 University Avenue West, Waterloo N2L 3G1, ON, Canada; e-mail: firstname.lastname@example.org
Funding for this review was provided in the form of a grant from Ciba Vision.
The authors have no other funding or conflicts of interest to disclose.
Accepted January 24, 2012